AAAAAA
Results: 1-25/55
Authors:
BENJAPIBAL M
KUDELKA AP
VASURATNA A
EDWARDS CL
VERSCHRAEGEN CF
VALERO V
VADHANRAJ S
KAVANAGH JJ
Citation: M. Benjapibal et al., DOCETAXEL AND CYCLOPHOSPHAMIDE-INDUCED REMISSION IN PLATINUM AND PACLITAXEL REFRACTORY OVARIAN-CANCER, Anti-cancer drugs, 9(6), 1998, pp. 577-579
Authors:
PROW D
VADHANRAJ S
Citation: D. Prow et S. Vadhanraj, THROMBOPOIETIN - BIOLOGY AND POTENTIAL CLINICAL-APPLICATIONS, Oncology, 12(11), 1998, pp. 1597
Authors:
GLISSON B
KOMAKI R
LEE JS
SHIN DM
FOSSELLA F
MURPHY WK
KURIE J
PEREZSOLER R
SCHEA R
VADHANRAJ S
Citation: B. Glisson et al., INTEGRATION OF FILGRASTIM INTO CHEMORADIATION FOR LIMITED SMALL-CELL LUNG-CANCER - A PHASE-I STUDY, International journal of radiation oncology, biology, physics, 40(2), 1998, pp. 331-336
Authors:
MURRAY LJ
LUENS KM
ESTRADA ME
BRUNO E
HOFFMAN R
COHEN RL
ASHBY MA
VADHANRAJ S
Citation: Lj. Murray et al., THROMBOPOIETIN MOBILIZES CD34(-BLOOD AND EXPANDS MULTILINEAGE PROGENITORS IN BONE-MARROW OF CANCER-PATIENTS WITH NORMAL HEMATOPOIESIS() CELL SUBSETS INTO PERIPHERAL), Experimental hematology, 26(3), 1998, pp. 207-216
Authors:
PATEL SR
VADHANRAJ S
BURGESS MA
PLAGER C
PAPADOPOLOUS N
JENKINS J
BENJAMIN RS
Citation: Sr. Patel et al., RESULTS OF 2 CONSECUTIVE TRIALS OF DOSE-INTENSIVE CHEMOTHERAPY WITH DOXORUBICIN AND IFOSFAMIDE IN PATIENTS WITH SARCOMAS, American journal of clinical oncology, 21(3), 1998, pp. 317-321
Authors:
CURRIE LM
VADHANRAJ S
LIVESEY SA
CONNOR J
Citation: Lm. Currie et al., HIGHER RETENTION OF FUNCTIONAL-ACTIVITY OF RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) INDUCED PLATELETS VERSUS NORMAL PLATELETS FOLLOWING LONG-TERM STORAGE WITH THROMBOSOL(TM), Transfusion, 38(10), 1998, pp. 243-243
Authors:
VADHANRAJ S
Citation: S. Vadhanraj, RECOMBINANT HUMAN THROMBOPOIETIN - CLINICAL-EXPERIENCE AND IN-VIVO BIOLOGY, Seminars in hematology, 35(3), 1998, pp. 261-268
Authors:
REDDY SP
HARWOOD RM
MOORE DF
GRIMM EA
MURRAY JL
VADHANRAJ S
Citation: Sp. Reddy et al., RECOMBINANT INTERLEUKIN-2 IN COMBINATION WITH RECOMBINANT INTERFERON-GAMMA IN PATIENTS WITH ADVANCED MALIGNANCY - A PHASE-1 STUDY, Journal of immunotherapy with emphasis on tumor immunology, 20(1), 1997, pp. 79-87
Authors:
PATEL SR
VADHANRAJ S
PAPADOPOLOUS N
PLAGER C
BURGESS MA
HAYS C
BENJAMIN RS
Citation: Sr. Patel et al., HIGH-DOSE IFOSFAMIDE IN BONE AND SOFT-TISSUE SARCOMAS - RESULTS OF PHASE-II AND PILOT-STUDIES - DOSE-RESPONSE AND SCHEDULE DEPENDENCE, Journal of clinical oncology, 15(6), 1997, pp. 2378-2384
Authors:
GLASPY J
BUKOWSKI R
STEINBERG D
TAYLOR C
TCHEKMEDYIAN S
VADHANRAJ S
Citation: J. Glaspy et al., IMPACT OF THERAPY WITH EPOETIN ALFA ON CLINICAL OUTCOMES IN PATIENTS WITH NONMYELOID MALIGNANCIES DURING CANCER-CHEMOTHERAPY IN COMMUNITY ONCOLOGY PRACTICE, Journal of clinical oncology, 15(3), 1997, pp. 1218-1234
Authors:
CURRIE LM
VADHANRAJ S
LIVESEY SA
CONNOR J
Citation: Lm. Currie et al., CRYOPRESERVATION OF PLATELETS FROM RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO)-TREATED DONORS USING THROMBOSOL(TM) AND 2-PERCENT DMSO, Transfusion, 37(9), 1997, pp. 10-10
Authors:
RAZA A
VADHANRAJ S
CHAVEZSANCHEZ G
Citation: A. Raza et al., MYELODYSPLASTIC SYNDROMES, Revista de Investigacion Clinica, 49, 1997, pp. 15-21
Authors:
KOREN E
MORAWORMS M
WARREN MK
SZABO JM
VADHANRAJ S
Citation: E. Koren et al., ASSESSMENT OF MEGAKARYOCYTE PROLIFERATION CAPACITY IN SARCOMA PATIENTS WHO RECEIVED MYELOID GROWTH-FACTORS FOLLOWING CHEMOTHERAPY, Blood, 90(10), 1997, pp. 3556-3556
Authors:
VADHANRAJ S
CURRIE LM
RAMOS C
LIVESEY SA
CONNOR J
Citation: S. Vadhanraj et al., ENHANCED RETENTION OF IN-VITRO FUNCTIONAL-ACTIVITY OF RHTPO-INDUCED PLATELETS FOLLOWING CRYOPRESERVATION WITH THROMBOSOL(TM) AND 2-PERCENT DMSO, Blood, 90(10), 1997, pp. 156-156
Authors:
VADHANRAJ S
PATEL S
GANO J
DONATO M
RAMOS C
PAPADOPOLOUS N
BURGESS A
PLAGER C
BAUM C
SHERMAN J
CHAMPLIN R
BROXMEYER HE
BENJAMIN RS
Citation: S. Vadhanraj et al., PHASE I-II STUDY OF MYELOPOIETIN (SC-68420) IN SARCOMA PATIENTS RECEIVING HIGH-DOSE IFOSFAMIDE CHEMOTHERAPY (C), Blood, 90(10), 1997, pp. 934-934
Authors:
VADHANRAJ S
VERSCHRAEGEN C
MCGARRY L
BUESORAMOS C
KUDELKA A
FREEDMAN R
EDWARDS C
BEVERS M
LEVENBACK C
GERSHENSON D
JONES D
YANG T
BAST RC
KAVANAGH J
Citation: S. Vadhanraj et al., RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) ATTENUATES HIGH-DOSE CARBOPLATIN (C)-INDUCED THROMBOCYTOPENIA IN PATIENTS WITH GYNECOLOGIC MALIGNANCY, Blood, 90(10), 1997, pp. 2581-2581
Authors:
VADHANRAJ S
MURRAY LJ
BUESORAMOS C
PATEL S
REDDY SP
HOOTS WK
JOHNSTON T
PAPADOPOLOUS NE
HITTELMAN WN
JOHNSTON DA
YANG TA
PATON VE
COHEN RL
HELLMANN SD
BENJAMIN RS
BROXMEYER HE
Citation: S. Vadhanraj et al., STIMULATION OF MEGAKARYOCYTE AND PLATELET PRODUCTION BY A SINGLE-DOSEOF RECOMBINANT HUMAN THROMBOPOIETIN IN PATIENTS WITH CANCER, Annals of internal medicine, 126(9), 1997, pp. 673
Authors:
MURRAY JL
KLEINERMAN ES
JIA SF
ROSENBLUM MG
ETON O
BUZAID A
LEGHA S
ROSS MI
THOMPSON L
MUJOO K
RIEGER PT
SALEH M
KHAZAELI MB
VADHANRAJ S
Citation: Jl. Murray et al., PHASE-IA IB TRIAL OF ANTI-GD2 CHIMERIC MONOCLONAL-ANTIBODY-14.18 (CH14.18) AND RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) IN METASTATIC MELANOMA/, Journal of immunotherapy with emphasis on tumor immunology, 19(3), 1996, pp. 206-217
Authors:
RITCHIE A
VADHANRAJ S
BROXMEYER HE
Citation: A. Ritchie et al., THROMBOPOIETIN SUPPRESSES APOPTOSIS AND BEHAVES AS A SURVIVAL FACTOR FOR THE HUMAN GROWTH FACTOR-DEPENDENT CELL-LINE, M07E, Stem cells, 14(3), 1996, pp. 330-336
Authors:
VERSCHRAEGEN CF
KUDELKA AP
TERMRUNGRUANGLERT W
DELEON CG
EDWARDS CL
FREEDMAN RS
KAVANAGH JJ
VADHANRAJ S
Citation: Cf. Verschraegen et al., EFFECTS OF INTERLEUKIN-1-ALPHA ON OVARIAN-CARCINOMA IN PATIENTS WITH RECURRENT DISEASE, European journal of cancer, 32A(9), 1996, pp. 1609-1611
Authors:
KUDELKA AP
TERMRUNGRUANGLERT W
VADHANRAJ S
EDWARDS CL
VARMA DG
TORNOS C
VERSCHRAEGEN CF
KAVANAGH JJ
Citation: Ap. Kudelka et al., REMISSION OF ADVANCED UTERINE LEIOMYOSARCOMA WITH PULMONARY METASTASES WITH CARBOPLATIN AND PACLITAXEL, Anti-cancer drugs, 7(8), 1996, pp. 885-889
Authors:
VADHANRAJ S
BURRIS H
BENJAMIN RS
PATEL S
JOHNSTON T
HELLMANN S
COHEN R
WATANABE B
VONHOFF D
Citation: S. Vadhanraj et al., SINGLE-DOSE THERAPY WITH RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) IN PATIENTS RECEIVING CYTOTOXIC CHEMOTHERAPY, Journal of clinical oncology, 14(5), 1996, pp. 2010-2010
Authors:
VADHANRAJ S
Citation: S. Vadhanraj, RECOMBINANT-HUMAN-ERYTHROPOIETIN IN COMBINATION WITH OTHER HEMATOPOIETIC CYTOKINES IN ATTENUATING CHEMOTHERAPY-INDUCED MULTILINEAGE MYELOSUPPRESSION - BRIEF COMMUNICATION, Seminars in hematology, 33(1), 1996, pp. 16-18
Authors:
REDDY SP
BUESORAMOS C
BOIKO I
HITTELMAN WN
VADHANRAJ S
Citation: Sp. Reddy et al., EFFECTS OF RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) ON BONE-MARROW MEGAKARYOCYTES IN HUMANS, Blood, 88(10), 1996, pp. 233-233
Authors:
MURRAY LJ
LUENS KM
BRUNO E
ESTRADA MF
COHEN RL
HELLMANN SD
HOFFMAN R
VADHANRAJ S
Citation: Lj. Murray et al., EFFECTS OF THROMBOPOIETIN ON MEGAKARYOCYTES AND PROGENITOR-CELL POPULATIONS IN BONE-MARROW AND PERIPHERAL-BLOOD OF SARCOMA PATIENTS, Blood, 88(10), 1996, pp. 1391-1391